Day One Biopharmaceuticals Inc (NASDAQ:DAWN) traded at $7.93 at close of the session on Monday, March 31 and made a downward move of -1.73% on its previous day’s price. Looking at the stock we see that its previous close was $8.07 and the beta (5Y
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) price on current trading day, rose 1.47% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $8.28. A look at the stock’s price movement, the close in the last trading session was $8.16,
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) traded at $8.07 at close of the session on Monday, March 10 and made a downward move of -6.92% on its previous day’s price. Day One Biopharmaceuticals Inc has a market cap of $817.93 million and is expected to release
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) shares, rose in value on Thursday, March 06, with the stock price down by -6.19% to the previous day’s close as strong demand from buyers drove the stock to $9.10. Actively observing the price movement in the last trading, the
The trading price of Day One Biopharmaceuticals Inc (NASDAQ:DAWN) closed lower on Monday, March 03, and closing at $8.25, -8.94% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $18.07 and a 52-week
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) concluded the trading at $12.43 on on Friday, February 21 with a rise of 1.64% from its closing price on previous day. Considering stock’s 52-week price range provides that DAWN hit a high price of $18.07 and saw its price
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
